This review describes the impact of nonmedical switching of biologic therapies on US patients and providers, with a focus on switching to in-class alternatives.
Dhaval Patil, MS, BPharm
Advertisement
Articles by Dhaval Patil, MS, BPharm
Advertisement
Latest Updated Articles
- Perspectives on Nonmedical Switching and the COVID-19 Pandemic: A Narrative Review
Published: September 26th 2022 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Newly Unveiled ACA Premiums Show 26% Average Increase Before Subsidy Expiration
2
FDA Guidance to Remove One of the Largest Barriers to Biosimilar Development
3
Boosting RSV Vaccination in Older Adults Could Save Thousands
4
Cancer Care in Transition: Navigating Breakthrough Therapies Amid Economic Strain
5
